GSK H1N1 bulk vaccine antigen at 15UG HA dose

Ended Awarded

Contract number
HHSO10033004T
Awardee
Awarding agency
Obligated
$181,134,000

Award facts

Opportunity
  • RFPHHSBARDA0825 Solicitation number
Contract value 100% obligated
$181,134,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competitive Delivery Order · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Philadelphia, PA 19102, USA

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract HHSO10033004T?

HHSO10033004T was awarded to Glaxosmithkline Holdings (Americas) Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on May 22, 2009.

How much is contract HHSO10033004T worth?

The government has obligated $181,134,000 on HHSO10033004T.

Is contract HHSO10033004T an order under another contract?

Yes. HHSO10033004T is a delivery order under HHSO100200800071I, an indefinite delivery contract.

Was contract HHSO10033004T competed?

The extent of competition for HHSO10033004T was competitive delivery order. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award